TWD 19.35
(-1.02%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 108.75 Million TWD | -26.1% |
2022 | 147.16 Million TWD | 43.91% |
2021 | 102.25 Million TWD | -1.73% |
2020 | 104.05 Million TWD | 189087.27% |
2019 | 55 Thousand TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 133.09 Million TWD | 22.39% |
2024 Q2 | 133.09 Million TWD | 0.0% |
2023 Q1 | 125.64 Million TWD | -14.62% |
2023 Q3 | 108.75 Million TWD | -13.44% |
2023 FY | 108.75 Million TWD | -26.1% |
2023 Q4 | 108.75 Million TWD | 0.0% |
2023 Q2 | 125.64 Million TWD | 0.0% |
2022 Q3 | 147.16 Million TWD | 0.0% |
2022 FY | 147.16 Million TWD | 43.91% |
2022 Q4 | 147.16 Million TWD | 0.0% |
2021 FY | 102.25 Million TWD | -1.73% |
2020 FY | 104.05 Million TWD | 189087.27% |
2019 FY | 55 Thousand TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Allied Biotech Corporation | 910.11 Million TWD | 88.051% |
GeneFerm Biotechnology Co., Ltd. | 282.53 Million TWD | 61.509% |
Easywell Biomedicals, Inc. | 589.98 Million TWD | 81.567% |
TTY Biopharm Company Limited | 3.36 Billion TWD | 96.772% |
Synmosa Biopharma Corporation | 3.62 Billion TWD | 97.002% |
Orient EuroPharma Co., Ltd. | 6.64 Billion TWD | 98.364% |
Center Laboratories, Inc. | 6.78 Billion TWD | 98.397% |
Tien Liang BioTech Co., Ltd. | 161.05 Million TWD | 32.474% |
Orient Pharma Co., Ltd. | 892.18 Million TWD | 87.811% |
InnoPharmax Inc. | 48.64 Million TWD | -123.544% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 320.99 Million TWD | 66.12% |
Excelsior Biopharma Inc. | 472.87 Million TWD | 77.002% |
DV Biomed Co., Ltd. | 765.87 Million TWD | 85.8% |
Foresee Pharmaceuticals Co., Ltd. | 616.93 Million TWD | 82.372% |
Handa Pharmaceuticals, Inc. | 280.88 Million TWD | 61.282% |
UniPharma Co., Ltd. | 37.4 Million TWD | -190.773% |
Anxo Pharmaceutical Co., Ltd. | 1.01 Billion TWD | 89.289% |
Alar Pharmaceuticals Inc. | 76.08 Million TWD | -42.927% |
Winston Medical Supply Co., Ltd. | 373.87 Million TWD | 70.912% |
Mercury Biopharmaceutical Corporation | 49.72 Million TWD | -118.724% |
TSH Biopharm Corporation Limited | 133.62 Million TWD | 18.615% |